Private Equity
The Japanese market is drawing a lot of attention right now, but integrating into the local community takes time, says LYFE Capital founder and partner James Zhao.
7 min read · 01 April 2026
From CVs on CVs to greater specialisation, secondaries professionals who have previously featured on our rising stars list share their insights on the market’s evolution.
6 min read · 05 March 2026
NPMI Fund II could be six times larger than its predecessor, PEI understands.
2 min read · 03 March 2026
From Japan Post Bank’s former private equity head to a buyout shop delivering 4.4x, PEI presents a rundown of seven managers you should probably get to know.
7 min read · 11 February 2026
Last year, the firm closed its third cycle of the evergreen fund dubbed Vivo Opportunity Fund with over $740m in commitments.
2 min read · 28 January 2026
The fund comes three years after the firm raised $3.3bn for its 14th flagship.
2 min read · 21 January 2026
Kip Kirkpatrick, senior partner, co-chairman and co-CEO at Vistria, told Buyouts the CV deal was a win-win for all the parties involved, including LPs.
3 min read · 20 January 2026
The healthcare investor aims to deploy 15-20% of its latest flagship into assets in the Gulf region, head of South Asia Sunil Thakur tells PEI.
3 min read · 17 December 2025
GL’s fundraise coincides with the September close of a $240m single-asset continuation fund backed by the Abu Dhabi Investment Authority.
3 min read · 26 November 2025
In a rebounding biotech market, royalty finance can play a far more strategic role, provided it’s executed with disciplined underwriting, smart structuring and a genuine partnership with innovators, according to Ryan Murr, a partner at Gibson, Dunn & Crutcher.
5 min read · 19 November 2025